Literature DB >> 6594999

Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion.

S Zimm, J J Grygiel, J M Strong, T J Monks, D G Poplack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6594999     DOI： 10.1016/0006-2952(84)90026-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.

Authors:  P Lafolie; O Björk; S Hayder; L Ahström; C Peterson
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Simultaneous Determination of 6-Mercaptopurine and its Oxidative Metabolites in Synthetic Solutions and Human Plasma using Spectrophotometric Multivariate Calibration Methods.

Authors:  Mohammad-Hossein Sorouraddin; Mohammad-Yaser Khani; Kaveh Amini; Abdolhossein Naseri; Davoud Asgari; Mohammad-Reza Rashidi
Journal:  Bioimpacts       Date:  2011-06-09

3.  6-mercaptopurine: high-dose 24-h infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; J M van Baal; M B van Leeuwen; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase.

Authors:  Kanika V Choughule; Carlo Barnaba; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2014-05-13       Impact factor: 3.922

Review 5.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.